IBP-9414

DRUG2 trials

Sponsors

Infant Bacterial Therapeutics

Conditions

Necrotizing Enterocolitis

Phase 2

IBP-9414 for the Prevention of Necrotizing Enterocolitis

CompletedNCT02472769

Infant Bacterial TherapeuticsNecrotizing Enterocolitis

Start: 2016-05-27End: 2017-08-07Updated: 2017-12-29

Phase 3

IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

Active, not recruitingNCT03978000

Infant Bacterial TherapeuticsNecrotizing Enterocolitis

Start: 2019-07-04End: 2024-07-31Updated: 2024-04-12